Supriya Lifescience Share Price Forecast to 2030

The Supriya Lifescience share price forecast for the next 3 years is a question on many investors' minds as the stock trades at Rs 859.90, within a 52 week range of Rs 546.00 to Rs 1,086. This article lays out a scenario based Supriya Lifescience share price outlook for 2027, 2028 and 2030, built on the company's fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.

Click Here – Get Free Investment Predictions

Supriya Lifescience Company Overview

Supriya Lifescience manufactures active pharmaceutical ingredients including antihistamines, vitamins and specialty APIs for domestic and global pharma companies. Understanding the business model is the first step in framing any credible Supriya Lifescience share price forecast, because the durability of earnings ultimately decides where the stock trades.

Company	Supriya Lifescience
NSE Ticker	SUPRIYA
CMP	Rs 859.90
52 Week High	Rs 1,086
52 Week Low	Rs 546.00
Market Cap	Rs 6921. Cr
Stock PE	33.0
Book Value	₹ 149
ROE	19.1 %
ROCE	25.1 %
Dividend Yield	0.12 %

Where Does Supriya Lifescience Share Price Stand Today?

The stock currently trades at Rs 859.90, within a 52 week range of Rs 546.00 to Rs 1,086. For anyone building a Supriya Lifescience share price forecast, this means the valuation starting point is a P/E of 33.0. How the broader Nifty 50 index trades over this period will also influence the multiple investors are willing to assign to the stock.

At the current price, Supriya Lifescience commands a market capitalisation of Rs 6921. Cr and trades at a price to earnings multiple of 33.0. The company generates a return on equity of 19.1 % and a return on capital employed of 25.1 %. These numbers anchor the Supriya Lifescience share price forecast scenarios that follow.

Supriya Lifescience Share Price Forecast: Key Growth Drivers for the Next 3 Years

The primary growth catalyst for Supriya Lifescience is rising global demand for specialty APIs and antihistamine intermediates and export market expansion. This driver is anchored in structural trends within the Pharmaceuticals sector.

Earnings Trajectory and Return Ratios

Stock prices ultimately follow earnings. The pace at which profits compound over FY27 to FY30 will be the single biggest determinant of the Supriya Lifescience share price forecast actually playing out. Consistent earnings delivery tends to expand valuation multiples, while misses compress them quickly.

Pharmaceuticals Sector Dynamics

Sector trends are a second key driver. Within the space, investors often benchmark Supriya Lifescience against peers such as Sudeep Pharma, NGL Fine-Chem, Gufic Biosciences on growth and valuations before forming a view on the Supriya Lifescience share price forecast for the next 3 years.

Balance Sheet and Debt Management

the ability to manage financial leverage will directly influence the Supriya Lifescience share price forecast. Companies that reduce debt or fund growth without diluting equity tend to see stronger share price appreciation.

Macro and Policy Environment

Interest rate cycles, currency movements and sector-specific policy changes will also shape the Supriya Lifescience share price forecast over the 2027 to 2030 horizon. These are harder to predict but need to be monitored closely.

Consult a SEBI Registered Investment Advisor Before Acting on Any Forecast

Key Risks to the Supriya Lifescience Share Price Forecast

The Supriya Lifescience share price forecast could be materially impacted by API pricing pressure from competitive generic manufacturers and regulatory compliance risk are key considerations. These risks are not unique to Supriya Lifescience but the degree of impact depends on the company's specific exposure and management quality.

Supriya Lifescience Share Price Forecast: 3-Year Scenario Table

The following indicative scenario analysis is illustrative only and does not constitute a research-grade price target. Actual outcomes will depend on company performance, sector dynamics, and macroeconomic conditions.

Scenario	3-Year Indicative Range	Key Assumptions
Bull Case	Rs 1,548	Strong execution, sector tailwinds materialise, margin expansion via operating leverage
Base Case	Rs 1,161	Steady growth broadly in line with sector, manageable cost pressures, stable demand conditions
Bear Case	Rs 644.92	Demand slowdown, margin compression from rising costs, or sector-specific headwinds materialise

These ranges are not investment advice. The bull case assumes key growth drivers materialise fully, while the bear case reflects meaningful headwinds. The base case represents a moderate, sector-average outcome.

Download the Univest iOS App or Univest Android App to track Supriya Lifescience share price and get real-time alerts.

Should You Invest in Supriya Lifescience?

Any investment in Supriya Lifescience must be evaluated against your own risk profile, investment horizon, and portfolio composition. The Supriya Lifescience share price forecast outlined here is scenario-based and not a guaranteed outcome. Key considerations are the growth drivers (rising global demand for specialty APIs and antihistamine intermediates and expo), the risks (API pricing pressure from competitive generic manufacturers and regulatory compl), and how those interact with your overall portfolio strategy.

Retail investors are always advised to consult a SEBI-registered investment advisor before taking any position. The Pharmaceuticals index provides a useful benchmark for comparing Supriya Lifescience share price performance against the broader sector.

Conclusion

The Supriya Lifescience share price forecast for the next 3 years ranges from Rs 644.92 in the bear case to Rs 1,548 in the bull case, with a base case around Rs 1,161. The primary driver is rising global demand for specialty APIs and antihistamine intermediates and expo, while the main risk is API pricing pressure from competitive generic manufacturers and regulatory compl. Investors should track quarterly results, balance sheet trends, and sector developments to refine their view as the forecast horizon approaches.

This article is for informational purposes only. Consult a SEBI-registered advisor before investing.

Frequently Asked Questions on Supriya Lifescience Share Price Forecast

What is the Supriya Lifescience share price forecast for the next 3 years?

Ans. The Supriya Lifescience share price forecast for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 644.92 in the bear case to Rs 1,548 in the bull case, with a base case near Rs 1,161, depending on earnings delivery and market conditions.

What is the Supriya Lifescience share price forecast for 2027?

Ans. For 2027, the scenario range works out to Rs 816.90 to Rs 1,118, with a base case around Rs 945.89. This assumes compounding on the current price of Rs 859.90 and is illustrative, not a guaranteed outcome.

What is the Supriya Lifescience share price forecast for 2028?

Ans. The 2028 scenario range is Rs 730.91 to Rs 1,290, with the base case near Rs 1,032. Actual levels will depend on earnings growth, sector trends and overall market valuations at the time.

What is the current share price of Supriya Lifescience?

Ans. Supriya Lifescience currently trades at around Rs 859.90 on the NSE, within a 52 week range of Rs 546.00 to Rs 1,086. Prices change continuously during market hours, so check live quotes before acting.

Is Supriya Lifescience a good stock for the long term?

Ans. Supriya Lifescience has a long term story built on rising global demand for specialty APIs and antihistamine intermediates and expo, but it also carries risks since API pricing pressure from competitive generic manufacturers and regulatory compl. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.

What is the Supriya Lifescience share price outlook for 2030?

Ans. The Supriya Lifescience share price outlook for 2030 spans Rs 644.92 to Rs 1,548 across bear and bull scenarios. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.

What are the key risks to the Supriya Lifescience share price forecast?

Ans. The main risks are API pricing pressure from competitive generic manufacturers and regulatory compliance risk are key c. Any of these can push the stock below the base case scenario discussed in this article.